M&A
confidence high
sentiment neutral
materiality 0.90
ENZO BIOCHEM INC: M&A transaction — Enzo Biochem completes merger with Bethpage Parent; stockholders to receive $0.70/share
ENZO BIOCHEM INC
- Merger closed August 20, 2025; each share converted to $0.70 cash per the Merger Agreement.
- Shares ceased trading on OTCQX; company to file Form 15 to deregister and suspend SEC reporting.
- Directors Pully, Radoff, Couchman, and Cannon resigned at the effective time.
- Certificate of incorporation and bylaws were amended and restated in connection with the merger.